Buerger H - Search Results

1

Grade I chondrosarcoma of bone: the Münster experience.

Streitbürger A, Ahrens H, Balke M, Buerger H, Winkelmann W, Gosheger G, Hardes J. Streitbürger A, et al. Among authors: buerger h. J Cancer Res Clin Oncol. 2009 Apr;135(4):543-50. doi: 10.1007/s00432-008-0486-z. Epub 2008 Oct 15. J Cancer Res Clin Oncol. 2009. PMID: 18855011

2

Primary multifocal osseous Hodgkin disease: a case report and review of the literature.

Gebert C, Hardes J, Ahrens H, Buerger H, Winkelmann W, Gosheger G. Gebert C, et al. Among authors: buerger h. J Cancer Res Clin Oncol. 2005 Mar;131(3):163-8. doi: 10.1007/s00432-004-0641-0. Epub 2004 Dec 15. J Cancer Res Clin Oncol. 2005. PMID: 15605165 Review.

3

Prognostic relevance of increased angiogenesis in osteosarcoma.

Kreuter M, Bieker R, Bielack SS, Auras T, Buerger H, Gosheger G, Jurgens H, Berdel WE, Mesters RM. Kreuter M, et al. Among authors: buerger h. Clin Cancer Res. 2004 Dec 15;10(24):8531-7. doi: 10.1158/1078-0432.CCR-04-0969. Clin Cancer Res. 2004. PMID: 15623635

4

High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy.

Leidinger B, Heyse T, Schuck A, Buerger H, Mommsen P, Bruening T, Fuchs S, Gosheger G. Leidinger B, et al. Among authors: buerger h. BMC Cancer. 2006 Jun 18;6:160. doi: 10.1186/1471-2407-6-160. BMC Cancer. 2006. PMID: 16780601 Free PMC article.

5

Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.

Kersting C, Gebert C, Agelopoulos K, Schmidt H, van Diest PJ, Juergens H, Winkelmann W, Kevric M, Gosheger G, Brandt B, Bielack S, Buerger H. Kersting C, et al. Among authors: buerger h. Clin Cancer Res. 2007 May 15;13(10):2998-3005. doi: 10.1158/1078-0432.CCR-06-2432. Clin Cancer Res. 2007. PMID: 17505002

6

En bloc spondylectomy in malignant tumors of the spine.

Liljenqvist U, Lerner T, Halm H, Buerger H, Gosheger G, Winkelmann W. Liljenqvist U, et al. Among authors: buerger h. Eur Spine J. 2008 Apr;17(4):600-9. doi: 10.1007/s00586-008-0599-8. Epub 2008 Jan 24. Eur Spine J. 2008. PMID: 18214553 Free PMC article.

7

Lack of toxicological side-effects in silver-coated megaprostheses in humans.

Hardes J, Ahrens H, Gebert C, Streitbuerger A, Buerger H, Erren M, Gunsel A, Wedemeyer C, Saxler G, Winkelmann W, Gosheger G. Hardes J, et al. Among authors: buerger h. Biomaterials. 2007 Jun;28(18):2869-75. doi: 10.1016/j.biomaterials.2007.02.033. Epub 2007 Mar 3. Biomaterials. 2007. PMID: 17368533

8

Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects.

Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, Gunsel A, Kemper FH, Winkelmann W, Von Eiff C. Gosheger G, et al. Among authors: buerger h. Biomaterials. 2004 Nov;25(24):5547-56. doi: 10.1016/j.biomaterials.2004.01.008. Biomaterials. 2004. PMID: 15142737

9

Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.

Kersting C, Packeisen J, Leidinger B, Brandt B, von Wasielewski R, Winkelmann W, van Diest PJ, Gosheger G, Buerger H. Kersting C, et al. Among authors: buerger h. J Clin Pathol. 2006 Jun;59(6):585-90. doi: 10.1136/jcp.2005.028373. Epub 2006 Feb 3. J Clin Pathol. 2006. PMID: 16461571 Free PMC article.

10

Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis.

Gebert C, Hardes J, Kersting C, August C, Supper H, Winkelmann W, Buerger H, Gosheger G. Gebert C, et al. Among authors: buerger h. Histopathology. 2007 Mar;50(4):491-7. doi: 10.1111/j.1365-2559.2007.02619.x. Histopathology. 2007. PMID: 17448025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page